REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2012

Sep 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2012-08-31

Reporting Person: GOLDBERG MURRAY A (SVP Finance and Admin CFO Trea)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-27	Common Stock	G	600.0	$0.0	Disposed	95810.0	Direct
2012-08-31	Common Stock	S	503.0	$144.59	Disposed	95307.0	Direct
2012-08-31	Common Stock	S	2691.0	$145.6	Disposed	92616.0	Direct
2012-08-31	Common Stock	S	1626.0	$146.37	Disposed	90990.0	Direct
2012-08-31	Common Stock	S	476.0	$147.21	Disposed	90514.0	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5560.0	Indirect

Footnotes

F1: Gift of Common Stock to charitable organization.

F2: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F3: Represents volume-weighted average price of sales of 503 shares of Company stock on August 31, 2012 at prices ranging from $144.00 to $144.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2012 at each separate price.

F4: Represents volume-weighted average price of sales of 2,691 shares of Company stock on August 31, 2012 at prices ranging from $145.03 to $145.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2012 at each separate price.

F5: Represents volume-weighted average price of sales of 1,626 shares of Company stock on August 31, 2012 at prices ranging from $146.06 to $146.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2012 at each separate price.

F6: Represents volume-weighted average price of sales of 476 shares of Company stock on August 31, 2012 at prices ranging from $147.10 to $147.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2012 at each separate price.